LEADER 01540nas  2200493 a 450 
001 996202956403316
005 20240413015804.0
011   $a1099-1077
035   $a(OCoLC)44061954
035   $a(CKB)954925551359
035   $a(CONSER)  2001212325
035   $a(DE-599)ZDB2001446-6
035   $a(EXLCZ)99954925551359
100   $a20000516a19869999  sy         a
101 0 $aeng
135   $aurmnu|||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aHuman psychopharmacology $eclinical and experimental
210   $a[Chichester, Sussex, England] $cJohn Wiley & Sons$dc1986-
225 1 $a1986- : Wiley medical publication
300   $aTitle from table of contents screen (Wiley InterScience; viewed: 9/14/2006).
300   $aRefereed/Peer-reviewed
311   $a0885-6222 
410  0$aWiley medical publication.
606   $aPsychopharmacology$vPeriodicals
606   $aPsychotropic drugs$vPeriodicals
606   $aPsychopharmacology
606   $aPsychotropic Drugs$xpharmacology
606   $aPsychopharmacologie$vPe?riodiques
606   $aPsychotropes$vPe?riodiques
608   $aPeriodical.
615  0$aPsychopharmacology
615  0$aPsychotropic drugs
615  2$aPsychopharmacology.
615  2$aPsychotropic Drugs$xpharmacology.
615  6$aPsychopharmacologie
615  6$aPsychotropes
676   $a615
906   $aJOURNAL
912   $a996202956403316
996   $aHuman psychopharmacology$92026037
997   $aUNISA